Display options
Cite
Babaee E, Tehrani-Banihashem A, Eshrati B, et al. How Much Hypertension is Attributed to Overweight, Obesity, and Hyperglycemia Using Adjusted Population Attributable Risk in Adults?. Int J Hypertens. 2020;2020:4273456doi: 10.1155/2020/4273456.
Babaee, E., Tehrani-Banihashem, A., Eshrati, B., Purabdollah, M., & Nojomi, M. (2020). How Much Hypertension is Attributed to Overweight, Obesity, and Hyperglycemia Using Adjusted Population Attributable Risk in Adults?. International journal of hypertension, 20204273456. https://doi.org/10.1155/2020/4273456
Babaee, Ebrahim, et al. "How Much Hypertension is Attributed to Overweight, Obesity, and Hyperglycemia Using Adjusted Population Attributable Risk in Adults?." International journal of hypertension vol. 2020 (2020): 4273456. doi: https://doi.org/10.1155/2020/4273456
Babaee E, Tehrani-Banihashem A, Eshrati B, Purabdollah M, Nojomi M. How Much Hypertension is Attributed to Overweight, Obesity, and Hyperglycemia Using Adjusted Population Attributable Risk in Adults?. Int J Hypertens. 2020 Aug 14;2020:4273456. doi: 10.1155/2020/4273456. eCollection 2020. PMID: 32855819; PMCID: PMC7443238.
Copy Download .nbib Format: NLM
Share it on

Int J Hypertens. 2020 Aug 14;2020:4273456. doi: 10.1155/2020/4273456. eCollection 2020.

How Much Hypertension is Attributed to Overweight, Obesity, and Hyperglycemia Using Adjusted Population Attributable Risk in Adults?.

International journal of hypertension

Ebrahim Babaee, Arash Tehrani-Banihashem, Babak Eshrati, Majid Purabdollah, Marzieh Nojomi

Affiliations

  1. Student Research Committee, Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran.
  2. Preventive Medicine and Public Health Research Center, Department of Community Medicine, Iran University of Medical Sciences, Tehran, Iran.
  3. Department of Nursing, Faculty of Nursing, Tabriz University of Medical Sciences, Tabriz, Iran.
  4. Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Community and Family Medicine Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

PMID: 32855819 PMCID: PMC7443238 DOI: 10.1155/2020/4273456

Abstract

BACKGROUND: High blood pressure (HBP) is a proven risk factor for cardiovascular diseases. So, determining the extent of the contribution of the factors associated with HBP seems to be necessary. Accordingly, this study aimed to investigate how much the prevalence of HBP attributed to obesity and high blood glucose (HBG).

METHODS: Data were collected from 7612 participants extracted from a screening program in 2018, in Iran, which was conducted on the subjects with the age of 30 years old and older to investigate the prevalence of HBP and their associated risk factors. To collect data, we used a standard checklist in terms of the WHO STEPS manual, and a stratified multistage sampling method was also applied. The adjusted population attributable risk of overweight, obesity, and HBG for HBP was calculated by the logistic regression model using the aflogit module.

RESULTS: Among the studied people, 7.4% of male and 10.8% of female subjects were hypertensive. The adjusted analysis showed that, in men, 27% and 41% and, among women, 19% and 37% of HBP prevalence rates were attributable to obesity (BMI ≥ 30) and fast blood sugar (FBS) (≥126), respectively. In people with both obesity and HBG, 59% of the prevalence rate of HBP in men and 46% of the prevalence in women were due to the abovementioned risk factors altogether. The results show that, if obesity and HBG were eliminated, the prevalence of HBP could be theoretically decreased from 7.4% to 5.4% and 4.3% in male subjects and from 10.8% to 8.7% and 6.8% in female subjects, respectively.

CONCLUSIONS: Our findings indicate that how much the prevalence of HBP attributes to obesity and HBG in middle-age and older population. It seems that the prevention programs should be administered in the general population, and excess body weight prevention programs should also be implemented in childhood.

Copyright © 2020 Ebrahim Babaee et al.

Conflict of interest statement

The authors of this paper declare that they have no conflicts of interest in this survey.

References

  1. J Pak Med Assoc. 2011 Jun;61(6):549-54 - PubMed
  2. Am J Public Health. 1998 Jan;88(1):15-9 - PubMed
  3. J Reprod Med. 1997 Sep;42(9):585-6 - PubMed
  4. Pak J Med Sci. 2015 Jan-Feb;31(1):239-42 - PubMed
  5. Metab Syndr Relat Disord. 2010 Jun;8(3):209-13 - PubMed
  6. Int J Hypertens. 2016;2016:1656938 - PubMed
  7. Diabetes Care. 2007 Mar;30(3):753-9 - PubMed
  8. J Hum Hypertens. 1999 Jul;13(7):425-30 - PubMed
  9. J Diabetes Metab Disord. 2014 Dec 23;13(1):121 - PubMed
  10. J Hypertens. 2013 Jul;31(7):1364-71; discussion 1371 - PubMed
  11. Circulation. 2000 Jan 25;101(3):329-35 - PubMed
  12. Public Health. 2016 Apr;133:14-8 - PubMed
  13. Diabetes Res Clin Pract. 2014 Feb;103(2):319-27 - PubMed
  14. Biometrics. 1993 Sep;49(3):865-72 - PubMed
  15. Iran J Public Health. 2012;41(3):71-81 - PubMed
  16. JAMA. 2002 Feb 27;287(8):1003-10 - PubMed
  17. J Clin Hypertens (Greenwich). 2013 Jan;15(1):14-33 - PubMed
  18. Am J Hypertens. 2015 Jan;28(1):89-97 - PubMed
  19. JAMA. 2010 Oct 27;304(16):1795-802 - PubMed
  20. Circulation. 2014 May 6;129(18):1832-9 - PubMed
  21. J Pediatr. 2011 Feb;158(2):257-64.e1-7 - PubMed
  22. Arch Dis Child. 2011 Sep;96(9):804-9 - PubMed
  23. Lancet. 2012 Jan 7;379(9810):47-54 - PubMed
  24. Arch Iran Med. 2016 Jul;19(7):456-64 - PubMed
  25. BMC Public Health. 2009 May 29;9:167 - PubMed
  26. Lancet. 2012 Aug 11;380(9841):601-10 - PubMed
  27. Int J Hypertens. 2017;2017:5491838 - PubMed
  28. Biomed Environ Sci. 2013 Jun;26(6):437-44 - PubMed
  29. Q J Med. 1986 Dec;61(236):1081-90 - PubMed

Publication Types